Related Experiment Video
Updated: Apr 18, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer Therapy
1Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, USA.
Abstract:
Next-generation antisense technologies are re-emerging as viable and powerful approaches to the treatment of several genetic diseases. Similar strategies are also being applied to cancer therapy. Re-programming of the expression of endogenous oncogenic products to replace them with functional antagonists, by interfering with alternative splicing or polyadenylation, provides a promising novel approach to address acquired drug resistance and previously undruggable targets.
Insights
Next-generation antisense technologies offer new treatments for genetic diseases and cancer. These advanced methods reprogram gene expression to combat drug resistance and target previously undruggable conditions.
Area of Science:
- Molecular Biology
- Genetics
- Pharmacology
Background:
- Next-generation antisense technologies are gaining traction for treating genetic disorders.
- These strategies are also being explored for novel cancer therapies.
Purpose of the Study:
- To investigate the potential of antisense technologies in reprogramming gene expression for therapeutic benefit.
- To explore the application of these technologies in overcoming challenges in cancer treatment, such as drug resistance and targeting previously intractable targets.
Main Methods:
- Interfering with alternative splicing processes.
- Modulating polyadenylation of messenger RNA.
- Developing functional antagonists for endogenous oncogenic products.
Main Results:
- Antisense strategies show promise in reprogramming oncogene expression.
- These approaches can potentially yield functional antagonists.
- The methods address acquired drug resistance and previously undruggable targets in cancer.
Conclusions:
- Next-generation antisense technologies represent a powerful therapeutic approach for genetic diseases and cancer.
- Reprogramming gene expression via splicing or polyadenylation interference offers a novel strategy for challenging medical conditions.
More Related Videos
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
MicroRNAs
MicroRNAs

